ZOSANO PHARMA INC

Profile

Company Names

ZOSANO PHARMA INC

Addresses

34790 ARDENTECH COURT, FREMONT, CA 94555

Phone Numbers

(510) 745-1200

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$46,825,891.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2011-04-29 
$4,705,630.00 
$4,705,630.00 
$0.00 
Debt 
2
2010-08-13 
$3,111,261.00 
$16,000,800.00 
$12,889,539.00 
Equity 
1
2009-06-18 
$39,009,000.00 
$39,009,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
M. 
JAMES 
BARNETT, PH.D. 
DIRECTOR
ZOSANO PHARMA INC
M. 
JAMES 
BARRETT, PH.D. 
DIRECTOR
SENSORS FOR MEDICINE + SCIENCE INC   |  ZOSANO PHARMA INC   |  SUPERNUS PHARMACEUTICALS INC
JOHN 
P. 
BROWN, PH.D. 
DIRECTOR
ZOSANO PHARMA INC
PETER 
 
DADDONA, PH.D. 
EXECUTIVE OFFICER
ZOSANO PHARMA INC
KIM 
 
GAUMER 
EXECUTIVE OFFICER
ZOSANO PHARMA INC
DANIEL 
 
HUNT 
EXECUTIVE OFFICER
ZOSANO PHARMA INC   |  COMENTIS INC   |  ES XPLORE, L.L.C.   |  CASCADE FINANCIAL TECHNOLOGY CORP
VIKRAM 
 
LAMBA 
EXECUTIVE OFFICER
PREDICTIVE BIOSCIENCES, INC   |  ZOSANO PHARMA INC   |  ZP HOLDINGS INC   |  ZOSANO, INC.   |  ZOSANO PHARMA CORP   |  MAGNUS MEDICAL, INC.   |  ANODYNE NANOTECH, INC.
DAVID 
M. 
MOTT 
DIRECTOR
NEW ENTERPRISE ASSOCIATES 13 LP   |  ZOSANO PHARMA INC   |  NEW ENTERPRISE ASSOCIATES 14, L.P.   |  NEA 15 OPPORTUNITY FUND, L.P.   |  TESARO, INC.   |  NEA BH SPV, L.P.
JOHN 
P. 
RICHARD 
DIRECTOR
ZOSANO PHARMA INC
MICHAEL 
 
SCHLAMP, PH.D. 
EXECUTIVE OFFICER
ZOSANO PHARMA INC
GAIL 
 
SCHULZE 
EXECUTIVE OFFICER, DIRECTOR
ZOSANO PHARMA INC
JEE 
Y. 
SHIN 
DIRECTOR
ZOSANO PHARMA INC
THORSTEN 
 
VON STEIN, M.D., PH.D. 
EXECUTIVE OFFICER
ZOSANO PHARMA INC
JOHN 
M. 
VUKO 
EXECUTIVE OFFICER
ZOSANO PHARMA INC
GREG 
 
YEDINAK 
EXECUTIVE OFFICER
ZOSANO PHARMA INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-09-23
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2011-04-29 
2011-06-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2011-04-29 
2010-08-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-13 
2010-03-30
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
N/A
NONE